Annual Congress on
Advancements in Neurology and Neuroscience

Biography:

Vise director of Department of Neurology, Tongren Hospital, Shanghai Jiao Tong University School of Medicine. She was graduated from Huashan Hospital, Fudan University and worked at Second Affiliated Hospital, Zhejiang University School of Medicine for 10 years. She has been studied at University of Califonia San Diego as Visiting Scholar for 2 years from 2008 to 2010. She is specialized in neuro-immune diseases and neuromuscular diseases and advanced on the research of myasthenia gravis and mitochondrial disease. Her publications including Autophagy(2017), J Immunol, (2013), Mitochondrion(2011) et al seven SCI publications and 20 Chinese publications.

Abstract:

To study the heteroplasmy and phenotype correlations of mtDNA 3243A>G mutation in 7 Han Chinese families using restrict fragment length polymorphism (RFLP) and pyrosequencing (Pyro). Methods Seven probands were pathologically and genetically diagnosed as mitochondrial diseases with 3243A>G mutation. The clinical phenotypes were studied in 39 maternal family members. 5 were diagnosed as mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS), 2 with pure mitochondrial myopathy (MM), 1 with early neuropathy, ataxia, and retinitis pigmentosa (NARP) syndrome. Six with diabetes, 3 with hearing loss, and 20 family members are normal. Blood DNA from 37 members were detected with RFLP and pyrosequencing. mtDNA 3243A>G heterogeneity were analyzed. Results Mutation load in blood of 5 MELAS patients were 15.7% by RFLP (29% by Pyro), 12.8% (19% by Pyro), 40.1% (53% by Pyro), 25.8% (30% by Pyro), 28.3% (59% by Pyro). Mutation load in 2 MM patients were 13.7% (29% by Pyro) and 76.8% (79% by Pyro), and that in the NARP patient was 20.0% (57% by Pyro). Six family members with diabetes were range from 3.7%-7.6% (0%-14% by Pyro). Three family members with hearing loss were range from 4%-18.2% (6%-18%). The mutation load of 14 normal family members range from 2% to 12.5% (0%-5% by Pyro). Detection by Pyro is more accurate than RFLP when mutation load is lower than 10%. The mutation load is higher in those earlier age of onset. Conclusion Pyrosequencing is more reliable when mutation load is lower than 10%. The mutation load is negatively correlate to the age of onset in this research.

Biography:

Vise director of Department of Neurology, Tongren Hospital, Shanghai Jiao Tong University School of Medicine. She was graduated from Huashan Hospital, Fudan University and worked at Second Affiliated Hospital, Zhejiang University School of Medicine for 10 years. She has been studied at University of Califonia San Diego as Visiting Scholar for 2 years from 2008 to 2010. She is specialized in neuro-immune diseases and neuromuscular diseases and advanced on the research of myasthenia gravis and mitochondrial disease. Her publications including Autophagy(2017), J Immunol, (2013), Mitochondrion(2011) et al seven SCI publications and 20 Chinese publications.

Abstract:

To study the heteroplasmy and phenotype correlations of mtDNA 3243A>G mutation in 7 Han Chinese families using restrict fragment length polymorphism (RFLP) and pyrosequencing (Pyro). Methods Seven probands were pathologically and genetically diagnosed as mitochondrial diseases with 3243A>G mutation. The clinical phenotypes were studied in 39 maternal family members. 5 were diagnosed as mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS), 2 with pure mitochondrial myopathy (MM), 1 with early neuropathy, ataxia, and retinitis pigmentosa (NARP) syndrome. Six with diabetes, 3 with hearing loss, and 20 family members are normal. Blood DNA from 37 members were detected with RFLP and pyrosequencing. mtDNA 3243A>G heterogeneity were analyzed. Results Mutation load in blood of 5 MELAS patients were 15.7% by RFLP (29% by Pyro), 12.8% (19% by Pyro), 40.1% (53% by Pyro), 25.8% (30% by Pyro), 28.3% (59% by Pyro). Mutation load in 2 MM patients were 13.7% (29% by Pyro) and 76.8% (79% by Pyro), and that in the NARP patient was 20.0% (57% by Pyro). Six family members with diabetes were range from 3.7%-7.6% (0%-14% by Pyro). Three family members with hearing loss were range from 4%-18.2% (6%-18%). The mutation load of 14 normal family members range from 2% to 12.5% (0%-5% by Pyro). Detection by Pyro is more accurate than RFLP when mutation load is lower than 10%. The mutation load is higher in those earlier age of onset. Conclusion Pyrosequencing is more reliable when mutation load is lower than 10%. The mutation load is negatively correlate to the age of onset in this research.